InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Demitrack Mark, Directeur Médical. Officer active across 1 company, notably TREVENA INC. Cumulatively, 6 reports have been recorded. Activity tracked since 2 December 2021. The latest transaction was disclosed on 17 December 2021 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
12,408 shares@ US$0.7080.66% mcap30.3% of flowCommon StockSEC:0001192482-21-000766
12,408 shares@ US$0.7080.66% mcap15.2% of flowCommon StockSEC:0001192482-21-000766:0
30,601 shares@ US$0.6534.8% of flowCommon StockSEC:0001879785-21-000034:0
30,601 shares@ US$0.6569.7% of flowCommon StockSEC:0001879785-21-000034
390,000 shares0Common StockSEC:0001879785-21-000026:0
390,000 shares0Common StockSEC:0001879785-21-000026
6 of 6 declarations
About Demitrack Mark
Mark Demitrack serves as Senior Vice President and Chief Medical Officer of Trevena Inc. In this role, he is responsible for leading the company's medical and clinical activities. Mark plays a key role in developing new treatments and guiding strategic medical decisions. His expertise in medicine and research is essential for the success of Trevena.
